Joint EMA/EORTC Workshop
29 February 2024
Amsterdam, NL (Hybrid Event)
The European Medicines Agency (EMA) and the European Organisation for Research and Treatment of Cancer (EORTC) are jointly organising a workshop called “How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions?”
This workshop will bring together international experts from academia, learned societies, patients, regulatory agencies, health technology assessment bodies, and industry.
Date: Thursday, 29 February 2024
Location: European Medicines Agency, Amsterdam
Next events
EORTC Pathobiology Autumn Group Meeting 2026
3 September - 4 September
Gmunden, Austria
EORTC Gastrointestinal Tract Cancer Group Autumn Meeting 2026
4 September - 5 September
Oxford, UK
EORTC Thyroid Cancer Group Autumn Meeting 2026
4 September
Porto, Portugal
SISAQOL pilot in-person training 2026
22 September - 23 September
Zagreb, Croatia
EORTC Brain Tumour Group Autumn Meeting 2026
23 September
Rome, IT
